Effects of ribavirin combined with interferon-α2b on viral kinetics during first 12 weeks of treatment in patients with hepatitis C virus genotype 1 and high baseline viral loads
✍ Scribed by M. Enomoto; S. Nishiguchi; M. Kohmoto; A. Tamori; D. Habu; T. Takeda; S. Seki; S. Shiomi
- Book ID
- 108885690
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 160 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1352-0504
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract This study evaluated an updated chemiluminescence enzyme immunoassay (CLEIA) for hepatitis C virus (HCV) core protein for monitoring viral kinetics during treatment with interferon (IFN)‐α and ribavirin. Using the CLEIA, serum levels of HCV core protein were measured in 17 patients with
## Abstract An investigation was carried out to determine whether early viral monitoring could predict efficiently the virological response to combination therapy of two different regimens in treatment‐naïve chronic hepatitis C patients infected with genotype 1b with high baseline viral load. Patie
## Abstract Patients with high viral load (≥1.0 × 10^5^ IU/ml) of hepatitis C virus (HCV) genotype 1b do not achieve high sustained virological response rates to interferon (IFN)/ribavirin combination therapy. Previous studies suggested that pretreatment amino acid (aa) substitution patterns in the